Unknown Bones, Joints & Muscles NIHR-supported project Infection & Immunity

Exploring HLA-B*27-targeted RNAi therapy for Ankylosing Spondylitis

Funder NIHR (part of DHSC)
Recipient organisation NIHR Oxford Biomedical Research Centre
NIHR support Recorded as supported by this research centre
Period Apr 2025 — Ongoing

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by NIHR.

Researchers

Paul Bowness (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Identification of HLA-B*27 bound peptides involved in the pathogenesis of Ankylosing Spondylitis and Reactive Arthritis
Modelling the cellular causes of HLA-B*27 associated spondyloarthritis with single-cell genomics
Identification and validation of novel T cell therapeutic targets in Ankylosing Spondylitis
Using immunopeptidomics and spatial genomics to determine the autoantigen, presenting cells and responding CD8 T cells in ankylosing spondylitis
Role of cGAS-STING/IFN-I pathway in the establishment of synovial B-cells niches and response to B-cell depleting therapies in rheumatoid arthritis

Original classification

Musculoskeletal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.